Global Pediatric Drugs And Vaccines Market Size By Technology (Live Attenuated, Inactivated), By Application (Infectious Diseases, Cancer), By Geographic Scope And Forecast

Pediatric Drugs And Vaccines Market Size And Forecast

Pediatric Drugs And Vaccines Market size was valued at USD 111.85 Billion in 2022 and is projected to reach USD 237.96 Billion by 2030, growing at a CAGR of 9.90% from 2024 to 2030.

An increase in the immunization programs from the Government Level, a rise in the R&D investment from Government, and Private players, and the growing success rate with mass vaccinations are the key market drivers. The Global Pediatric Drugs And Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Pediatric Drugs And Vaccines Market Definition

Pediatric vaccines are those that are given to children to protect them against dangerous infectious and non-infectious diseases. Inactive viruses are occasionally used as adjuvants in these vaccines. These inactivated viruses are no longer able to spread any diseases. However, the addition gives the vaccination additional strength, making the body’s immune system prone to infections from the outside. These vaccines help the body to produce antibodies against viruses. In this way, vaccines help children develop a protective shield against harmful viruses.

The availability of vaccines saves approximately 2 to 3 Million lives per year. A wide range of therapeutic areas are covered by pediatric drugs, including antibiotics, analgesics, respiratory, gastrointestinal, and vaccinations. To ensure safety and effectiveness, these medications are produced in dosages and formulations suitable for children. Vaccines play an important role in pediatric healthcare by preventing the spread of infectious diseases. Without actually causing the disease, they aid in stimulating the immune system to develop an immunological response.

To protect children from illnesses including measles, mumps, rubella, diphtheria, pertussis, tetanus, polio, hepatitis, influenza, and more, vaccinations are frequently given during infancy and childhood. To ensure that children receive the best possible medical care, it is crucial that safe, effective Pediatric Drugs And Vaccines be developed and made readily available. In order to maximize the advantages and reduce any potential hazards related to these treatments, proper adherence to dosage, administration suggestions, and safety precautions is essential. It is crucial to seek the advice of healthcare providers, including pediatricians, while using and administering medications and immunizations for pediatric.

Global Pediatric Drugs And Vaccines Market Overview

Population density is increasing worldwide. With the increase in population density, the government is conscious about increasing employment facilities. Developments of roads, buildings, and infrastructure are of prime importance for increasing employment. So, Governments are trying to reduce the undue expenditure on Healthcare. To reduce this expenditure mass level vaccination drives are conducted by Governments across all levels. These immunization programs will restrain the spread of dangerous viruses. Government programs conducted for vaccination helps the children whose family lacks health insurance or can’t afford the vaccination programs. In the US, the Centers for Medicare and Medicaid Services (CMS) offers the funding to the Center for Disease Control (CDC) for such drives. Thus, the rising vaccination drives are the most important market drivers for the Pediatric Drugs and Vaccine Market.

According to WHO, the vaccination drives help in reducing 3 Million deaths every year. Another 1.5 Million deaths can be avoided if the vaccination programs improve. According to a 2015 report by the CDC, Vaccination helped in reducing 21 Million hospitalizations, 322 Million illnesses, and more than 7 Lakh child deaths between 1994 and 2013. These benefits further encourage Governments to conduct mass-level Vaccination. As a result, several Private Agencies and NGOs are also increasing their investment in developing and spreading vaccines. This growing impetus from Government and Private levels is accelerating the market growth. There is an increase in chronic diseases worldwide. Several viruses like SARS, MERS, Corona, Plague, Yellow Virus, etc. The prevalence of diseases worldwide is making most people conscious. As a result, more vaccines are being administered to avoid dangerous infections. Infants are more prone to succumb to these diseases.

Thus, the widespread increase in harmful viruses is another reason behind the increase in Infant Vaccine consumption. Biological research is a very slow process and takes a very long time to get the desired results. Any kind of biological invention needs to be tested in phases and may produce different effects among different individuals. In the US, any vaccine needs to be approved by CDC and FDA, in India vaccines need to be approved by Central Drugs Standard Control Organization (CDCSCO), etc. Thus it makes a very complex process. This becomes time taking. This is one of the Market Restraints. However, during the time of emergency, the approval process becomes very fast. Several types of research are going on and advanced digital technologies are utilized at every stage of the invention process. These technologies give artificial simulation to accelerate the research. These effects will reduce the delay. The huge market demand due to the deadly viruses will provide a big opportunity for this market.

Global Pediatric Drugs And Vaccines Market Segmentation Analysis

The Global Pediatric Drugs And Vaccines Market is Segmented on the basis of Technology, Application, and Geography.

Pediatric Drugs And Vaccines Market, By Technology

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Based on Technology, the market is segmented into Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others. Conjugate Vaccines has the highest share. Conjugate Vaccines are further expected to increase much more in the coming years. This is mainly due to the pneumococcal and meningococcal diseases. There has been a rise in these diseases. As a result, for providing restraining power against these viruses the need for conjugate vaccines is much felt.

Pediatric Drugs And Vaccines Market, By Application

• Infectious Diseases
• Cancer
• Allergies

Based on Application, the market is segmented into Infectious Diseases, Cancer, and Allergies. Infectious Diseases have the highest market share. This is due to the increase in harmful contagious viruses like MERS, Corona, and Plague, etc. The mortality rate due to these viruses is much more. As a result, there is a growing concern about these viruses among common people. Thus, vaccines due to Infectious Diseases are much more in demand than other types.

Pediatric Drugs And Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Based on regional analysis, the Global Pediatric Drugs And Vaccines Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has the highest market for pediatric vaccines. The average investments from the Government Level behind healthcare facilities are much more than in other countries. Besides this, the number of immunization programs conducted by Government and Private Organizations is high in North America. Also, the R&D investment in North America is much more from the Government and Private companies.

Key Players

The “Global Pediatric Drugs And Vaccines Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Serum Institute of India, GlaxoSmithKline plc, Merck Sharp & Dohme Corp., SANOFI, AstraZeneca, Pfizer, Inc., Zydus Cadila, Indian Immunologicals Limited, Mitsubishi Tanabe Pharma Corporation, Panacea Biotec.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Pediatric Drugs And Vaccines Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Pediatric Drugs And Vaccines Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research